MJoTAtalks

Dr Susanna's guide to

www.MJoTA.org
click here

www.MJoTAtalks.org click here

www.drsusanna.org click here



Dr Susanna loves the countries and the peoples of Africa
 
Bookmark and Share
Diabetes news from the American Diabetes Association

Latest Top (20) News
Diabetes News
Diabetes news from the National Institutes of Health Diabetes Educators.

Latest Top (10) News
Clinical trials testing therapies for diabetes

Latest Top (10) News


A Mechanistic Randomized Controlled Trial on the Cardiovascular Effect of Berberine
Condition:   Cardiovascular Risk Factor
Interventions:   Drug: Berberine;   Drug: Placebo
Sponsors:   The University of Hong Kong;   Food and Health Bureau, Hong Kong
Not yet recruiting

Mon, 10 Dec 2018 12:00:00 EST


Clinical Decision Support Algorithm to Predict Diabetic Retinopathy
Condition:   Diabetic Retinopathy
Intervention:   Other: risk factors for diabetic retinopathy
Sponsors:   Oklahoma State University Center for Health Sciences;   Oklahoma State University;   University of Oklahoma
Not yet recruiting

Mon, 10 Dec 2018 12:00:00 EST


Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Efpeglenatide SAR439977;   Drug: Placebo;   Drug: Metformin;   Drug: Sulfonylurea
Sponsor:   Sanofi
Not yet recruiting

Mon, 10 Dec 2018 12:00:00 EST


Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
Conditions:   Type 2 Diabetes Mellitus;   Inadequate Glucose Control
Intervention:   Drug: duvie
Sponsors:   Pusan National University Hospital;   Chong Kun Dang Pharmaceutical Corp.
Not yet recruiting

Mon, 10 Dec 2018 12:00:00 EST


Insulin Fiasp During Pregnancy and Laction in Women With Pre-existing Diabetes
Conditions:   Diabetes Mellitus;   Pregnancy Complications
Intervention:   Drug: Faster-acting Aspart insulin
Sponsor:   Rigshospitalet, Denmark
Not yet recruiting

Mon, 10 Dec 2018 12:00:00 EST


Pilot Study of Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery
Condition:   Hyperinsulinemic Hypoglycemia
Interventions:   Drug: Glucagon RTU;   Other: Placebo
Sponsor:   Xeris Pharmaceuticals
Not yet recruiting

Mon, 10 Dec 2018 12:00:00 EST


Teneligliptin and Atorvastatin DDI Study
Condition:   Diabete Mellitus
Interventions:   Drug: Teneligliptin;   Drug: Atorvastatin;   Drug: Teneligliptin + Atorvastatin
Sponsor:   Handok Pharmaceuticals Co., Ltd.
Not yet recruiting

Mon, 10 Dec 2018 12:00:00 EST


The Effect of GIP(3-30)NH2
Condition:   Increasing Insulin
Interventions:   Other: GIP receptor antagonist;   Other: GIP receptor agonist;   Other: Saline
Sponsors:   University Hospital, Gentofte, Copenhagen;   Steno Diabetes Center;   University of Copenhagen
Active, not recruiting

Mon, 10 Dec 2018 12:00:00 EST


The Effect of Simvastatin Combined With Ezetimibe in Patients With Stable Angina and Diabetes
Condition:   Coronary Heart Disease
Interventions:   Drug: Ezetimibe with simvastatin;   Drug: Simvastatin
Sponsor:   Chinese PLA General Hospital
Recruiting

Mon, 10 Dec 2018 12:00:00 EST


The Effects of Different Doses of Exercise on Pancreatic β-cell Function in Patients With Newly Diagnosed Type 2 Diabetes
Conditions:   Type 2 Diabetes Mellitus;   Type2 Diabetes;   Diabetes Mellitus, Type 2;   Type2 Diabetes Mellitus
Interventions:   Behavioral: Exercise and diet;   Behavioral: Diet
Sponsor:   Mathias Ried-Larsen
Not yet recruiting

Mon, 10 Dec 2018 12:00:00 EST
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
FDA clears a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder

Mon, 10 Dec 2018 15:23:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs
FDA releases guidance with recommendations for protecting patients from the risk of contaminated or substandard compounded products produced by outsourcing facilities.

Mon, 10 Dec 2018 10:26:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics
FDA releases new strategic framework to advance use of real-world evidence to support development of drugs and biologics

Thu, 06 Dec 2018 10:58:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products
Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of vitro companion diagnostics for classes of oncology therapeutic products

Thu, 06 Dec 2018 09:32:00 -0500


FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care

Tue, 04 Dec 2018 11:12:00 -0500


FDA authorizes first test to aid in detecting a type of herpes virus in newborns called cytomegalovirus
FDA authorizes first test to aid in detecting a type of herpes virus in newborns called cytomegalovirus

Fri, 30 Nov 2018 15:51:00 -0500


FDA warns company for selling e-liquids that resemble kid-friendly foods as part of the agency’s ongoing Youth Tobacco Prevention Plan
FDA issued a warning letter to Electric Lotus LLC for selling nicotine-containing e-liquids used in e-cigarettes with labeling and/or advertising that cause them to resemble kid-friendly food products.

Thu, 29 Nov 2018 09:27:00 -0500


FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
FDA approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder. This is the first FDA approval of a treatment for LEMS.

Wed, 28 Nov 2018 18:10:00 -0500


FDA approves treatment for adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a certain genetic mutation
The FDA approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.

Wed, 28 Nov 2018 15:38:00 -0500


FDA approves first biosimilar for treatment of adult patients with non-Hodgkin’s lymphoma
The FDA approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin’s lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

Wed, 28 Nov 2018 13:10:00 -0500